Scrip Regulatory Affairs
EU medicines agency not suited to perform device evaluations, says commission report
13 April 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Comparative efficacy should have a formal role in EU drug licensing, researchers say
- US FDA invites feedback on IOM advice to scrap 510(k) process
- EU Council proposes ways to improve medical device regulations and facilitate path for innovation
- EU to strengthen ethical assessment of trial data in drug approval dossiers
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
